FMC's (FMC) Q1 results were weighed down by pricing headwinds from cost pass-through and generic competition, which are likely to persist through the rest of H1, RBC Capital Markets said in a note emailed Friday.
The firm said that FMC expects new product launches and growth in the plant health segment to drive year-over-year improvement in H2, but the company would need a solid H2 beat to boost investor confidence.
Price and foreign exchange pressures remained a headwind in April, slightly offset by better volume and costs, RBC said.
FMC expects destocking to be largely resolved by the end of Q2 in all regions except Asia, according to the note.
The firm maintained its sector perform rating on FMC's stock with a $40 price target.
Shares of FMC were down 1.5% in recent trading.
Price: 37.89, Change: -0.56, Percent Change: -1.46
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。